Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Full-length optic nerve regeneration in the absence of genetic manipulations
Qian Feng, Kimberly A. Wong, Larry I. Benowitz
Qian Feng, Kimberly A. Wong, Larry I. Benowitz
View: Text | PDF
Research Article Inflammation Neuroscience

Full-length optic nerve regeneration in the absence of genetic manipulations

  • Text
  • PDF
Abstract

The inability of mature retinal ganglion cells (RGCs) to regenerate axons after optic nerve injury can be partially reversed by manipulating cell-autonomous and/or -nonautonomous factors. Although manipulations of cell-nonautonomous factors could have higher translational potential than genetic manipulations of RGCs, they have generally produced lower levels of optic nerve regeneration. Here, we report that preconditioning resulting from mild lens injury (conditioning LI, cLI) before optic nerve damage induced far greater regeneration than LI after nerve injury or the pro-inflammatory agent zymosan given either before or after nerve damage. Unlike zymosan-induced regeneration, cLI was unaltered by depleting mature neutrophils or T cells or blocking receptors for known inflammation-derived growth factors (oncomodulin, stromal cell–derived factor 1, CCL5) and was only partly diminished by suppressing CCR2+ monocyte recruitment. Repeated episodes of LI led to full-length optic nerve regeneration, and pharmacological removal of local resident macrophages with the colony stimulating factor 1 receptor inhibitor PLX5622 enabled some axons to reinnervate the brain in just 6 weeks, comparable to the results obtained with the most effective genetic manipulations of RGCs. Thus, cell-nonautonomous interventions can induce high levels of optic nerve regeneration, paving the way to uncovering potent, translatable therapeutic targets for CNS repair.

Authors

Qian Feng, Kimberly A. Wong, Larry I. Benowitz

×

Figure 2

Removing naive resident macrophages with CSF1R inhibitor PLX5622 further enhances cLI-induced regeneration.

Options: View larger image (or click on image) Download as PowerPoint
Removing naive resident macrophages with CSF1R inhibitor PLX5622 further...
(A) Experimental timeline. Mice were fed with PLX5622 (PLX) or control chow from 14 days prior to LI or sham surgery until time of euthanasia. LI or sham surgery was performed 14 days before ONC, and mice were euthanized 4 weeks later. CTB, cholera toxin B fragment. (B) Representative longitudinal sections through the optic nerve showing CTB-labeled regenerating axons day 28 post-ONC. Note increase in regeneration when cLI is combined with PLX treatment. White line indicates the crush sites. Scale bar, 500 μm. Insets at right show magnified images of regenerating axons near optic chiasm in white and yellow dashed boxes from third and fourth sections. Scale bar, 100 μm. (C) Quantitation of regenerating axons at multiple distances from crush site in B (unpaired t test, P = 0.0131 at 1 mm; 0.0035 at 2 mm, 0.200 at 3 mm, and 0.018 at 4 mm. n = 5 mice per group). *P < 0.05, **P < 0.01.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts